7 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18278078 | INHIBITORS OF EPHB3 SIGNALING | SHIAO, REI TSANG | 1691 | Non-Final OA | Aug 21, 2023 |
| 18276540 | Pectin Compositions and Methods of Use | CHANG, KYUNG SOOK | 1613 | Non-Final OA | Aug 09, 2023 |
| 18014947 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Peptide Epitopes | WANG, RUIXUE | 1672 | Non-Final OA | Jan 06, 2023 |
| 18012111 | Single Molecule Assays for Ultrasensitive Detection of Biomolecules | MARCSISIN, ELLEN JEAN | 1677 | Non-Final OA | Dec 21, 2022 |
| 17698617 | METHODS OF SUPPRESSING MICROGLIAL ACTIVATION | HECK, BRYAN WILLIAM | 1644 | Non-Final OA | Mar 18, 2022 |
| 17291922 | An lncRNA integrates a DNA-PK-mediated DNA damage response and vascular senescence | MCKILLOP, JOHN CHARLES | 1637 | Non-Final OA | May 06, 2021 |
| 17284919 | The long non-coding RNA INCA1 and Homo sapiens heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1) as therapeutic targets for immunotherapy | TRAN, CHRISTINA L | 1637 | Final Rejection | Apr 13, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial